Flow Cytometry is fastest growing segment fueling growth of the Global Flow Cytometry Market

 The global Flow Cytometry Market is estimated to be valued at US$ 6280.32 Mn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Flow cytometry is a technique used to detect and measure physical and chemical characteristics of a population of cells or particles. By suspending cells in a stream of fluid and passing them through an electronic detection apparatus, characteristics such as size, granularity and the content of each individual cell or particle can be analyzed. This enables counting, sorting and characterization of cells.

Market key trends:

Flow cytometry is gaining immense demand across research institutes and clinical laboratories due to advantages such as high-throughput screening, ability to screen thousands of cells within a few seconds, and simultaneous measurement of up to 14 parameters per cell. Additionally, technological advancements such as cell sorters with a throughput of over 100,000 cells per second, compact analyzers and viability dyes enabling live cell sorting have boosted adoption. rising incidence of chronic diseases such as cancer is compelling the need for effective diagnostic techniques, driving demand for modern flow cytometers. Furthermore, growing stem cell research for drug discovery and regenerative medicine will continue fostering market growth over the forecast period.

Segment Analysis

The global flow cytometry market is dominated by cell sorting analysis segment. Flow cytometry allows sorting of heterogeneous population of cells as per the expression of cell surface markers. Cell sorting helps researchers isolate specific subset of cells from heterogeneous population for downstream applications such as for cell counting or detecting biomarkers on sorted cell populations. It has wide applications in research institutes, pharmaceutical and biotechnology companies for identification and purification of stem cells, circulating tumor cells, etc. The cell sorting segment accounted for the largest market share in 2022 owing to growing adoption of cell sorting techniques in stem cell research and clinical trials.

Key Takeaways

The Global Flow Cytometry Market Size is expected to witness high growth, exhibiting a CAGR of 10% over the forecast period, due to increasing demand for early disease diagnosis and technological advancements in flow cytometry techniques.

Regional analysis: North America dominated the global flow cytometry market in 2022 owing to rising adoption of flow cytometry techniques in research activities and presence of leading market players in the region. Asia Pacific is expected to exhibit the fastest growth over the forecast period due to growing pharmaceutical and biotechnology industries as well as increasing investments by government and private players to strengthen healthcare infrastructure.

Key players: Key players operating in the flow cytometry market are General Electric, BD, Luminex Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec GmbH., Sysmex Corporation, Agilent Technologies, Inc., Danaher, Enzo Life Sciences, Inc., Cytek Biosciences, Sartorius AG, BioLegend, Inc., Beckman Coulter, Inc., Laboratory Corporation of America Holdings., and MilliporeSigma. These players are focusing on new product launches and strategic collaborations to strengthen their market position.


Get more insights on this topic:

https://www.dailyprbulletin.com/flow-cytometry-market-size-analysis/

Comments

Popular posts from this blog

3D ICs Market to Reach US$ 22.5 Bn by 2023

Navigating the Future: Geospatial Analytics Market Trends Unveiled

The Rise of On-Demand Entertainment Drives Growth in the OTT Content Market